Biz Money; With Expansion Nearing Completion, ImmuCell Girds for FDA Vetting

Authors

Source

Mainebiz

Date

11-27-2017

Volume Number

VOL. XXIII, NO. XXVII

Pages

11-11

Abstract

ImmuCell Corp is a publicly traded animal health company and they are gearing up for more growth with a new $20.8 Million Portland production site. They plan to make an antimicrobial substance to treat mastitis in dairy cows and will be applying for FDA approval for the new product.

Subjects

ImmuCell Corp., FDA Approval, Mastitis, Dairy Cows

Recommended Citation

"Biz Money; With Expansion Nearing Completion, ImmuCell Girds for FDA Vetting" (2017). Maine News Index – MaineBiz. 7199.
https://digitalcommons.portlandlibrary.com/news_mainebiz/7199